MedTrace Logo

Post Market Evaluation of Acessa With TAG

NCT01842789 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2017-08-18

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to test both user preference and speed of targeting with the use of the Acessa System with Targeting Animation Guidance (TAG).

Conditions

  • Uterine Fibroids

Interventions

DEVICE

Acessa Procedure

Acessa Procedure

Sponsors & Collaborators

  • Acessa Health, Inc.

    lead INDUSTRY

Principal Investigators

  • Donald I Galen, MD · Donald I Galen Consulting

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01842789 on ClinicalTrials.gov